Treatment of Ph′-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (INTRON A)
- 31 January 1988
- journal article
- clinical trial
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 15, 21-26
- https://doi.org/10.1016/0305-7372(88)90070-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Therapy of chronic myelogenous leukemiaCancer, 1987
- Chronic myelogenous leukaemia: haematological remissions with alpha interferonBritish Journal of Haematology, 1986
- Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1986
- Suppression of clonal evolution in two chronic myelogenous leukaemia patients treated with leucocyte interferonBritish Journal of Haematology, 1985
- Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemiaBlood, 1983
- Reporting results of cancer treatmentCancer, 1981
- Staging of Chronic Myeloid LeukaemiaBritish Journal of Haematology, 1981
- METAMORPHOSIS OF CHRONIC GRANULOCYTIC LEUKAEMIA: DIAGNOSIS, CLASSIFICATION, AND MANAGEMENTBritish Journal of Haematology, 1979